NCAB GROUP AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.8 SEK | +10.64% |
|
+18.46% | +0.75% |
| Apr. 26 | Nordic Shares Closed Up Friday; Medicover Series B Climbed Highest | DJ |
| Apr. 25 | Transcript : NCAB Group AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Strengths
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 35.47 and 30.02 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.48 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Semiconductors
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +0.75% | 1.26B | B | ||
| -0.99% | 49.04B | B- | ||
| -7.22% | 16.73B | B | ||
| +16.63% | 11.25B | B+ | ||
| +49.91% | 8.75B | D+ | ||
| +3.69% | 8.53B | B | ||
| +6.14% | 7.56B | B- | ||
| -17.23% | 7.51B | B- | ||
| -12.95% | 6.83B | B | ||
| -14.19% | 6.74B | C- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NCAB Stock
- Ratings NCAB Group AB
